Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kalaris Therapeutics, Inc. | 222,000 | reported | 19 Mar 2026 | tx 3+985,611 |
| Aimmune Therapeutics, Inc. | 0 | reported | 13 Oct 2020 | tx 14+324,920−246,170 |
| ADURO BIOTECH, INC. | 0 | reported | 11 Aug 2023 | tx 4+200,000−200,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Mar 2026 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 222,000 | 0.00 USD | deriv |
| 10 Apr 2025 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 287,000 | 0.00 USD | deriv |
| 18 Mar 2025 | GRANT_AWARD | Kalaris Therapeutics, Inc. | 476,611 | — | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 40,000 | — | deriv |
| 11 Aug 2023 | OTHER | ADURO BIOTECH, INC. | 160,000 | 18.18 USD | deriv |
| 28 Feb 2023 | GRANT_AWARD | ADURO BIOTECH, INC. | 160,000 | 0.00 USD | deriv |
| 28 Feb 2023 | GRANT_AWARD | ADURO BIOTECH, INC. | 40,000 | 0.00 USD | deriv |
| 10 Oct 2020 | TENDER | Aimmune Therapeutics, Inc. | 6,345 | 34.50 USD | |
| 13 Oct 2020 | OTHER | Aimmune Therapeutics, Inc. | 20,250 | 34.50 USD | |
| 13 Oct 2020 | OTHER | Aimmune Therapeutics, Inc. | 67,500 | 10.69 USD | deriv |
| 13 Oct 2020 | OTHER | Aimmune Therapeutics, Inc. | 150,000 | 12.56 USD | deriv |
| 15 Sept 2020 | TAX_WITHHOLDING | Aimmune Therapeutics, Inc. | 840 | 34.25 USD | |
| 10 May 2020 | GRANT_AWARD | Aimmune Therapeutics, Inc. | 2,420 | 0.00 USD | |
| 13 Mar 2020 | PURCHASE | Aimmune Therapeutics, Inc. | 3,000 | 14.76 USD | |
| 22 Jan 2020 | TAX_WITHHOLDING | Aimmune Therapeutics, Inc. | 1,235 | 33.23 USD | |
| 28 Feb 2020 | GRANT_AWARD | Aimmune Therapeutics, Inc. | 11,250 | 0.00 USD | |
| 28 Feb 2020 | GRANT_AWARD | Aimmune Therapeutics, Inc. | 67,500 | 0.00 USD | deriv |
| 22 Jan 2019 | GRANT_AWARD | Aimmune Therapeutics, Inc. | 12,000 | 0.00 USD | |
| 22 Jan 2019 | GRANT_AWARD | Aimmune Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |